Key Highlights

Risk & Performance

Based on historical performance

High Risk

Score: 100/100

Failure Rate

66.7%

4 terminated/withdrawn out of 6 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

1 recruiting

No phase data available

Loading network data...

Showing 6 of 6 trials

Identifying Patterns in the Breath of Individuals With Breast Cancer

Role: lead

Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection Patients Using Infrared Spectroscopy

Role: collaborator

Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer

Role: lead

Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy

Role: lead

Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy

Role: lead

Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy

Role: collaborator

All 6 trials loaded